Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Faizus Sazzad has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • Theo Kofidis

    Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore

    20 shared publications
  • Theo Kofidis

    Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    7 shared publications
  • Ashlynn Ler

    School of Medicine, National University of Ireland, Galway, Ireland

    4 shared publications
  • Farooque Ahmed

    Head of the Department, Dept. of Cardiac Surgery, Ibrahim Cardiac Hospital & Research Institute, Dhaka, Bangladesh

    4 shared publications
  • Prasanta Kumar Chanda

    Assistant Professor & Associate Consultant, Department of Cardiac Anaesthesiology, Ibrahim Cardiac Hospital & Research Institute, Dhaka, Bangladesh

    4 shared publications
  • Zhi Xian Ong

    Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    4 shared publications

Latest Publications

  • Open Access

    Endoscopic mitral valve repair—one hundred and one ways to use neochords: a narrative review

    by Faizus Sazzad, Thomas Theologou, Christos Goutzios, Theo Kofidis

    Background and Objective: Mitral valve repair for mitral regurgitation remains technically demanding due to the complex anatomy of the mitral apparatus, including the annulus, left ventricle, papillary muscles, and chordae. Although Alain Carpentier’s “French Correction” laid foundational principles, repair remains challenging, particularly for junior or low-volume surgeons. Neochordal implantation is a critical tool in mitral repair but lacks standardized technique selection, leading to variability in outcomes and surgical training. This narrative review aims to provide a comprehensive classification of neochordal repair techniques and a structured framework to guide clinical application. Methods: A narrative review of published literature on neochordal implantation was conducted, emphasizing technique evolution, anatomical considerations, imaging guidance, and minimally invasive approaches. Over 100 techniques were identified and categorized by anchoring strategy, leaflet involvement, and integration with advanced technologies, including robotic and artificial intelligence (AI)-assisted planning. The review also considers educational tools, simulation methods, and credentialing practices relevant to neochordal repair. Key Content and Findings: Endoscopic mitral valve repair offers patient benefits by avoiding sternotomy but increases technical complexity. Current surgical strategies largely depend on institutional habits, with limited structured guidance. Innovations highlighted include single- and multi-point anchoring, Y-shaped configurations, and techniques optimized using advanced imaging and simulation. These methods allow precise tension distribution, minimize leaflet manipulation, and enhance reproducibility. Despite these advancements, most techniques lack high-level evidence, with data primarily from single-center or retrospective studies. Emerging approaches show promise for biomechanically optimized repairs that simplify complex procedures, potentially reducing mid-term reoperation rates. Training limitations, absence of standardized checklists, and variability in credentialing remain barriers to widespread adoption. Conclusions: Neochordal implantation represents a versatile and evolving component of mitral valve repair. While numerous innovative techniques exist, reproducible outcomes require multicenter validation, long-term follow-up, and standardized training frameworks. This review provides a structured classification of neochordal techniques, identifies emerging trends, and underscores the need for future research and educational standardization to improve surgical consistency and patient outcomes.

  • Open Access

    Innovative balloon-inflatable venous cannula for enhanced cardiopulmonary bypass in minimally invasive cardiac surgery

    by Faizus Sazzad, Ki Han Kim, Irwan Shah Bin Mohd Moideen, Abdulrahman El Gohary, John C Stevens, Theo Kofidis

    OBJECTIVES: Minimally invasive cardiac surgery (MICS) struggles with effective caval isolation and cannulation for cardiopulmonary bypass (CPB). We aimed to develop a novel MICS venous cannula, eliminating external manipulations. The goal of this study is to thoroughly evaluate both the safety and the efficacy of a newly developed venous cannula. METHODS: The study presents the Aulus venous cannula for MICS, designed with internal balloons to block caval blood flow. Preclinical bench tests with a cardiac biosimulator and large animal studies per ISO10993-2016, evaluated performance and safety. RESULTS: The heparin-coated Aulus cannula had a post-sterilization comparable density of ∼0.200 μg/cm2. In ex vivo tests, using porcine heart models, the cannula enabled full caval occlusion, with endoscopic views confirming precise positioning. The pressure drop remained below the haemolytic threshold of 100 mmHg, indicated lower values compared to BioMedicus. A non-Good Laboratory Practice (GLP) large animal study included eight ovine models, divided into short- and long-term follow-up groups. Clinical pathology values were consistent CPB procedures, and histopathology indicated favourable tolerance despite short-term vessel injuries and long-term stenosis with fibrosis. CONCLUSIONS: The Aulus cannula showed effective anticoagulant activity, strong integrity, and good tolerance in vitro and in vivo, highlighting its clinical potential.

  • Open Access

    Frozen Elephant Trunk Technique to Minimize Circulatory Arrest and Aortic Cross-Clamp Time

    by Faizus Sazzad, Mofassel Uddin Ahmed, Jai Ajitchandra Sule, Mohd Haidzir Mohamed, Shakil Farid, Sorokin Vitaly


  • Open Access

    Three-Dimensional Modelling of Indexed Papillary Muscle Displacement in Patients Requiring Mitral Valve Surgery Using Four-Dimensional Echocardiography Variables

    by Zhi Xian Ong, Ashlynn Ai Li Ler, Liang Shen, Theo Kofidis, Lian-Kah Ti, Faizus Sazzad

    Background: Two-dimensional and three-dimensional echocardiographic imaging are commonly used in assessing ischemic mitral regurgitation (IMR) and degenerative mitral regurgitation (DMR) in patients with mitral valve disease. However, the use of 4D echocardiographic imaging has not yet been reported. The objectives of this study were to explore the efficacy of utilizing 4D echocardiographic variables, determine papillary muscle displacement in patients with either IMR or DMR, and compare the differences in papillary muscle displacement between groups. Methods: Thirty-four patients were divided into two groups: Group 1 (with IMR) and Group 2 (with DMR). Using clinical ultrasound software, 4D echocardiographic variables were obtained and compared between the groups. Pearson’s product–moment correlation test was used to assess the relationship between the presence of IMR and both papillary muscle displacement and indexed papillary muscle displacement. Results: The mean values for papillary muscle displacement in Groups 1 and 2 were 38 ± 6.7 mm and 31.8 ± 6.1 mm, respectively. Indexed papillary muscle displacement was 22.8 ± 3.7 mm in Group 1 and 18.4 ± 3.5 mm in Group 2. There were statistically significant correlations between the presence of IMR and papillary muscle displacement (p = 0.009) and indexed papillary muscle displacement (p = 0.002). A significant correlation was also observed between IMR and PL (p = 0.001), with mean values of 15.7 ± 3.9 mm in Group 1 and 20.2 ± 5.6 mm in Group 2. Conclusions: Four-dimensional echocardiography is effective in evaluating morphological variations in IMR. It successfully determined papillary muscle displacement in patients undergoing mitral valve surgery and demonstrated a positive correlation between IMR and indexed papillary muscle displacement.


  • Open Access

    A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery

    by Sagar Sharma, Jie Hui Nah, Venkateswaran Siddarth, Haoxing Lai, Shen Liang, Zhi Xian Ong, Duoduo Wu, Haidong Luo, Guohao Chang, Giap Swee Kang, et al.

    Background The use of intraaortic balloon pump (IABP) effectively reduces left ventricular afterload and significantly increases coronary perfusion pressure by raising aortic diastolic pressure. This study examined the short and medium-term outcomes of 22,540 adult cardiac surgical patients requiring an IABP. Methods From 2009 to 2018, 1114 patients (4.94%) undergoing open-heart surgery at a single tertiary cardiac hospital received IABP support and were included in this retrospective study. They were categorized into pre-operative (Group A, n = 577), intra-operative (Group B, n = 475), and post-operative (Group C, n = 62) IABP insertion groups. Results Cardiogenic shock occurred in 11.2% of cases, mainly in Group A. Hemodynamic instability (38.8%) drove IABP use in Groups A and C, while difficulty weaning from CPB was the primary reason in Group C. The overall operative mortality rate was 10.9%, highest at 25.8% postoperatively. Multivariate analysis identified significant predictors of mortality: age (OR: 1.067, 95% CI: 1.041–1.094, p < 0.001), higher BMI (OR: 1.071, 95% CI: 1.017–1.128, p = 0.009), pulmonary hypertension (OR: 2.085, 95% CI: 1.302–3.341, p = 0.002), renal disease (OR: 2.780, 95% CI: 1.556–4.967, p < 0.001), and cardiogenic shock (OR: 3.684, 95% CI: 2.066–6.569, p < 0.001). Complications were more common in Group C, especially with renal disease. Average preoperative and postoperative stays were 4.0 ± 4.8 days and 15.2 ± 20.4 days, respectively, with no significant differences between groups. Conclusion IABP might offer safety for open-heart surgery, with longer hospital stays potentially associated with high-risk patients. Pre-operative IABP prophylaxis could be crucial in high-risk open-heart cases to reduce mortality. Clinical registration number: NHG DSRB Ref No# 2016/01070 and 2019/00397.


  • Novel Retractor–Camera System Facilitates Less Traumatic Minimally Invasive Procedures and Declutters the Operation Field

    by Faizus Sazzad, Wee Han Ng, Gao Feng, Irwan Shah Bin Mohd Moideen, Abdulrahman El Gohary, Ki Han Kim, John C. Stevens, Theo Kofidis

    Objective: To develop a novel endoscopic system that reduces trauma to the patient and declutters the surgical field for the surgeon in minimally invasive heart valve surgery. Methods: We designed and developed a retractor–camera combination for minimally invasive heart surgery; the cable and camera were connected to the underbelly of the left atrial retractor blade to provide an illuminated, wide-angle view of the mitral valve. We conducted ex vivo, in vivo, and, ultimately, a first-in-man randomized, nonanonymized clinical trial on 20 patients who required minimally invasive mitral valve surgery. Data from the preoperative period and the immediate postoperative period were gathered, and patients were followed for 3 months. Results: Our camera–retractor combo demonstrated safe and efficient exposure and vision in all detailed studies. The total operation time for the intervention group (316.5 ± 65.1 min) was slightly shorter than for the control group (317.5 ± 50.8 min). There was no significant difference in the ability to provide exposure of the mitral valve and surrounding left atrial tissue for both control and test articles. The novel camera–retractor reduced clutter in the operation field substantially and eliminated chest penetration for the camera. We also observed that the camera did not fog, did not stain with blood, and did not require frequent corrections to its position. Conclusions: We launch a novel atrial retraction–imaging platform that is less invasive for the patient and eliminates clutter and redundant movements for the surgeon.

  • Open Access

    Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?

    by Faizus Sazzad, Hai Dong Luo, Guohao Chang, Duoduo Wu, Zhi Xian Ong, Theo Kofidis, Giap Swee Kang

    Background: The aim of this study was to determine whether pre-operative intra-aortic balloon pump (IABP) insertion improves surgical outcomes in high-risk coronary artery bypass grafting (CABG) patients. Methods: Patients with a EuroSCORE II greater than 1.2% who underwent CABG from 2009 to 2016 were included in the study, while those who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing preoperative IABP insertion (EuroSCORE II > 5.018%) and 1198 patients in the non-IABP group before matching; after propensity score matching (PSM), both groups consisted of a matched cohort of 250 patients. Results: 30-day mortality events occurred in 9 (3.6%) non-IABP group and in 12 (4.8%) IABP patients (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p = 0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value = 0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value = 0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value = 0.011). Conclusion: Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders.


  • Open Access

    A Comprehensive Clinical Outcome Analysis of Endoscopic Vessel Harvesting for Coronary Artery Bypass Surgery

    by Hari Kumar Sampath, Terence Ji Hui Lee, Chua E. Cher, Shen Liang, Ooi Oon Cheong, Theo Kofidis, Sorokin Vitaly, Faizus Sazzad

    Background: The long saphenous vein is routinely used for coronary bypass graft (CABG) surgery, and two primary techniques are commonly utilized: endoscopic vessel harvesting (EVH) and open vessel harvesting (OVH). The aim of this study was to compare the clinical outcomes of the EVH and OVH techniques used for CABG within the confines of a tertiary hospital. Methods: The clinical data of all patients subjected to either EVH or OVH for CABG surgery between 2014 and 2018 were retrospectively analyzed. Statistical analysis was performed to discern variations in the rates of postoperative complications between EVH and OVH. Results: A cohort of 1884 individuals were included in this study, 75.3% of whom underwent EVH. Notably, the incidence of postoperative leg wound complications was significantly different between the patients who underwent OVH and the patients who underwent EVH, with incidence rates of 18.6% and 32%, respectively (p < 0.001). Leg wound complications (p < 0.001; OR 1.946; 95% CI 1.528–2.477) and leg wound infections (p = 0.050, OR 1.517, 95% CI 0.999–2.303) were significantly associated with OVH. Moreover, leg wound hematoma (p = 0.039, OR = 0.402, 95% CI = 0.169–0.957) and EVH were strongly associated. Conclusions: The large sample of patients and the inclusion of a range of Asian ethnic groups provided notable insights into postoperative complications related to different modalities. EVH was associated with a lower incidence of postoperative leg wound complications, which suggests that EVH is a better modality for those undergoing CABG surgery.


  • Open Access

    Harnessing the power of artificial intelligence in predicting all-cause mortality in transcatheter aortic valve replacement: a systematic review and meta-analysis

    by Faizus Sazzad, Ashlynn Ai Li Ler, Mohammad Shaheryar Furqan, Linus Kai Zhe Tan, Hwa Liang Leo, Ivandito Kuntjoro, Edgar Tay, Theo Kofidis

    Objectives: In recent years, the use of artificial intelligence (AI) models to generate individualised risk assessments and predict patient outcomes post-Transcatheter Aortic Valve Implantation (TAVI) has been a topic of increasing relevance in literature. This study aims to evaluate the predictive accuracy of AI algorithms in forecasting post-TAVI mortality as compared to traditional risk scores.Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses for Systematic Reviews (PRISMA) standard, a systematic review was carried out. We searched four databases in total—PubMed, Medline, Embase, and Cochrane—from 19 June 2023–24 June, 2023.Results: From 2,239 identified records, 1,504 duplicates were removed, 735 manuscripts were screened, and 10 studies were included in our review. Our pooled analysis of 5 studies and 9,398 patients revealed a significantly higher mean area under curve (AUC) associated with AI mortality predictions than traditional score predictions (MD: −0.16, CI: −0.22 to −0.10, p < 0.00001). Subgroup analyses of 30-day mortality (MD: −0.08, CI: −0.13 to −0.03, p = 0.001) and 1-year mortality (MD: −0.18, CI: −0.27 to −0.10, p < 0.0001) also showed significantly higher mean AUC with AI predictions than traditional score predictions. Pooled mean AUC of all 10 studies and 22,933 patients was 0.79 [0.73, 0.85].Conclusion: AI models have a higher predictive accuracy as compared to traditional risk scores in predicting post-TAVI mortality. Overall, this review demonstrates the potential of AI in achieving personalised risk assessment in TAVI patients.Registration and protocol: This systematic review and meta-analysis was registered under the International Prospective Register of Systematic Reviews (PROSPERO), under the registration name “All-Cause Mortality in Transcatheter Aortic Valve Replacement Assessed by Artificial Intelligence” and registration number CRD42023437705. A review protocol was not prepared. There were no amendments to the information provided at registration.Systematic Review Registration: https://www.crd.york.ac.uk/, PROSPERO (CRD42023437705).


  • Open Access

    Systematic review of first-in-human and early phase clinical trials for surgically implantable biological mitral valve substitutes

    by Faizus Sazzad, Ying Kiat Tan, Li Xuan Beverly Chan, Irwan Shah Bin Mohd Moideen, Abdulrahman El Gohary, John C. Stevens, K. R. Ramanathan, Theo Kofidis

    Background: The aim of this review was the creation of uniform protocols to carry out and disclose First-In-Human and preliminary clinical trials of biological mitral valve replacement. The need for consistent methodology in these early trials was highlighted by the observation of significant variability in the methods and protocols used across different research. Methods: An extensive search through six major databases was carried out to retrieve First-In-Human (FIH) clinical studies evaluating surgically implanted bio-prostheses in the mitral position. Results: Following the PRISMA guideline, a systematic search identified 2082 published articles until March 2023. After removing duplicates (189), 1862 citations were screened, resulting in 22 eligible studies with 3332 patients for analysis. The mitral valve prostheses in these studies ranged from 21 to 37 mm, with the 29 mm size being most prevalent. Patient numbers varied, with the FIH subgroup including 31 patients and the older subgroup including 163 patients. Average study durations differed: the older subgroup lasted 4.57 years, the FIH subgroup 2.85 years, and the early phase studies spanned 8.05 years on average. Conclusion: FIH clinical report is essential to assess the significance of clinical data required for a “de novo” surgical implant. In addition, understanding the performance of the device, and recognizing the difficulties associated with the innovation constitute important lessons. These insights could be beneficial for the development of bioprosthetic heart valves and formulating a protocol for an FIH clinical trial.